Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04106089 · ClinicalTrials.gov registry record · NA

Sleep in Pediatric HSCT

A NA study, sponsored by Children's Hospital of Philadelphia.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT04106089: Completed NA study, sponsored by Children's Hospital of Philadelphia.

NCT04106089 is a NA study that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04106089, a NA study, has completed, sponsored by Children's Hospital of Philadelphia.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

Through an aggregated N=1 randomized controlled design (each patient will serve as their own control, with the 5-day intervention period determined by randomization), the current study will test the acceptability, feasibility, and impact on sleep and supportive care engagement of protecting one 6-hour window for nighttime sleep (intervention) relative to regular vitals checks (observation only periods) during Hematopoietic Stem Cell Transplant (HSCT) recovery.

Primary Outcome

Brief questionnaire created for this study evaluating the patient's acceptability of adjusting vitals checks. Participants reported agreement with each statement on a 5-point likert scale from not at all (1) to extremely (5). Higher values indicate greater agreement.

Interventions

  • BEHAVIORAL Extended time between vitals check

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2019-11-18
Est. Completion 2022-12-01
Phase NA
Children's Hospital of Philadelphia

431 total trials

What the finished NCT04106089 record still lists

NCT04106089 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Extended time between vitals check is the first listed.

NCT04106089 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04106089 about?

NCT04106089 is a clinical study titled "Sleep in Pediatric HSCT". Through an aggregated N=1 randomized controlled design (each patient will serve as their own control, with the 5-day intervention period determined by randomization), the current study will test the acceptability, feasibility, and impact on sleep and supportive care engagement of protecting one 6-ho...

What is the current status of trial NCT04106089?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2019-11-18. Estimated completion is 2022-12-01.

What interventions are being tested in trial NCT04106089?

The interventions under investigation include: Extended time between vitals check (BEHAVIORAL).

Who is sponsoring clinical trial NCT04106089?

This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04106089's enrollment target sits among peer trials

50 1279th of 2000 higher than 622 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04106089, the US trial registry maintained by the National Library of Medicine. NCT04106089 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.